2-Phenyl-3,6-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine.[1] Based on what is known from other phenylmorpholines with similar structure, it likely acts as a serotonin reuptake inhibitor and may produce antidepressant-like effects. Anecdotal reports suggest, however, that the compound is inactive aside from anorectic effects.
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.274 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
See also
edit- 3-Fluorophenmetrazine
- G-130 (2-Phenyl-5,5-dimethylmorpholine)
- 3,4-Phendimetrazine (2-Phenyl-3,4-dimethylmorpholine)
- PDM-35 (3,5-Phendimetrazine) (2-Phenyl-3,5-dimethylmorpholine)
- Manifaxine
- Radafaxine
References
edit- ^ DE patent 1143201, Siemer S, Doppstadt A, "Verfahren zur Herstellung von 2-Phenyl-3,6-dimethylmorpholine", granted 1963-02-07